About Federal State Budgetary Scientific Institution Research Institute of Rheumatology V.A. Nasonova
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Federal State Budgetary Scientific Institution Research Institute of Rheumatology V.A. Nasonova
During the past decade, Federal State Budgetary Scientific Institution Research Institute of Rheumatology V.A. Nasonova conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 8 clinical trials were completed, i.e. on
average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia
1992-05-01
2006-01-01
Completed
134
SWOG-9133 RT w/ or w/o Doxorubicin and Vinblastine in Stage I or Stage II Hodgkin's Disease
1992-09-01
2014-04-01
Completed
348
Cyclophosphamide and Filgrastim in Treating Patients With Stage IV, Relapsed, or Refractory Low-Grade Follicular Non-Hodgkin's Lymphoma
1992-10-01
2006-01-01
Completed
29
Aspirin in Treating Patients With Colorectal Cancer That Has Been Surgically Removed
1993-05-01
2006-01-01
Completed
635
SWOG-9208 Quality of Life and Health Status in Patients With Stage I or Stage II Hodgkin's Disease
1994-04-01
2005-05-01
Completed
263
Vinorelbine + Cisplatin or No Further Therapy in Non-small Cell Lung Cancer That Has Been Surgically Removed
1994-07-07
2009-12-21
Completed
482
S9415 Chemotherapy in Patients With Stage II or III Colon Cancer That Has Been Surgically Removed
1994-12-01
2005-03-01
Completed
1,135
Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors
1994-09-01
2006-07-01
Completed
270
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Federal State Budgetary Scientific Institution Research Institute of Rheumatology V.A. Nasonova" #1 sponsor was "Pfizer" with 4 trials, followed by "Biocad" with 3 trials
sponsored, "State Scientific Centre of Coloproctology, Russian Federation" with 3 trials sponsored, "Genentech, Inc." with 2 trials sponsored and "Hoffmann-La Roche"
with 2 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Federal State Budgetary Scientific Institution Research Institute of Rheumatology V.A. Nasonova"
#1 collaborator was "Astrakhan State Medical University" with 1 trials as a collaborator, "City Clinical Hospital №24, Department of Health City of Moscow" with 1 trials as a collaborator, "GBUZ MO "Lvovskaia Raionaia Bolnica"" with 1 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator and "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 8 trials.
Clinical Trials Conditions at Federal State Budgetary Scientific Institution Research Institute of Rheumatology V.A. Nasonova
According to Clinical.Site data, the most researched conditions in "Federal State Budgetary Scientific Institution Research Institute of Rheumatology V.A. Nasonova" are
"Cardiovascular Disease" (2 trials), "Chronic Anal Fissure" (2 trials), "Rheumatoid Arthritis" (2 trials), "Ulcerative Colitis" (2 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Federal State Budgetary Scientific Institution Research Institute of Rheumatology V.A. Nasonova" in a lesser frequency.
Clinical Trials Intervention Types at Federal State Budgetary Scientific Institution Research Institute of Rheumatology V.A. Nasonova
Most popular intervention types in "Federal State Budgetary Scientific Institution Research Institute of Rheumatology V.A. Nasonova" are "Drug" (13 trials), "Other" (3 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Filgotinib" (2 trials), "GDC-0853" (2 trials), "Methylprednisolone" (2 trials) and "Obinutuzumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Federal State Budgetary Scientific Institution Research Institute of Rheumatology V.A. Nasonova
The vast majority of trials in "Federal State Budgetary Scientific Institution Research Institute of Rheumatology V.A. Nasonova" are
14 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Federal State Budgetary Scientific Institution Research Institute of Rheumatology V.A. Nasonova
Currently, there are NaN active trials in "Federal State Budgetary Scientific Institution Research Institute of Rheumatology V.A. Nasonova".
undefined are not yet recruiting,
6 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Federal State Budgetary Scientific Institution Research Institute of Rheumatology V.A. Nasonova,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Federal State Budgetary Scientific Institution Research Institute of Rheumatology V.A. Nasonova, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 2 trials that are defined as “Not Applicable".